Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis

Free Radical Biology and Medicine

Volumn 117, Issue , 2018, Pages 45-57

  Jelinek, Anja ^a,b   Heyder, Lukas ^a   Daude, Michael ^a   Plessner, Matthias ^a   Krippner, Sylvia ^a   Grosse, Robert ^a   Diederich, Wibke E ^a   Culmsee, Carsten ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

BID; Ferroptosis; GPX4; HT22 cells; Mitoquinone; RSL3

Indexed keywords

BI 6C9; CASPASE 9; CHLOROACETAMIDE; CHONDROITIN SULFATE IRON; CRISPR ASSOCIATED PROTEIN; DEFEROXAMINE; FERROSTATIN 1; GLUTATHIONE PEROXIDASE; LIPROXSTATIN 1; MITOQUINONE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PROTEIN BID; PROTEIN INHIBITOR; RSL 3; UNCLASSIFIED DRUG; 10-(6'-UBIQUINONYL)DECYLTRIPHENYLPHOSPHONIUM BROMIDE; ANTIOXIDANT; CARBOLINE DERIVATIVE; ORGANOPHOSPHORUS COMPOUND; PHOSPHOLIPID-HYDROPEROXIDE GLUTATHIONE PEROXIDASE; RSL3 COMPOUND; UBIQUINONE;

ANIMAL CELL; ARTICLE; CELL LOSS; CELL PROTECTION; CELL VIABILITY; CELLS BY BODY ANATOMY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; FERROPTOSIS; FIBROBLAST; FRAGMENTATION REACTION; HT22 CELL LINE; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MITONCHONDRIAL FUNCTION; MITONCHONDRIAL INTEGRITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; CELL DEATH; CELL LINE; DRUG EFFECT; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARBOLINES; CELL DEATH; CELL LINE; FIBROBLASTS; GLUTATHIONE PEROXIDASE; MICE; MITOCHONDRIA; NEURONS; ORGANOPHOSPHORUS COMPOUNDS; UBIQUINONE;

EID: 85041395401     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2018.01.019     Document Type: Article

References (34)

1. Lin, M.T., Beal, M.F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:7113 (2006), 787–795.
2. Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:5 (2012), 1060–1072.
3. Doll, S., Proneth, B., Tyurina, Y.Y., Panzilius, E., Kobayashi, S., Ingold, I., et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13:1 (2017), 91–98.
4. Kagan, V.E., Mao, G., Qu, F., Angeli, J.P.F., Doll, S., Croix, C.S., et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat. Chem. Biol. 13:1 (2017), 81–90.
5. Speer, R.E., Karuppagounder, S.S., Basso, M., Sleiman, S.F., Kumar, A., Brand, D., et al. Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators: from ferroptosis to stroke. Free Radic. Biol. Med. 62 (2013), 26–36.
6. Markesbery, W.R., Lovell, M.A., Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19:1 (1998), 33–36.
7. Williams, T.I., Lynn, B.C., Markesbery, W.R., Lovell, M.A., Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol. Aging 27:8 (2006), 1094–1099.
8. Chen, L., Na, R., Gu, M., Richardson, A., Ran, Q., Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. J. Neurochem. 107:1 (2008), 197–207.
9. Joshi, Y.B., Giannopoulos, P.F., Pratico, D., The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease. Trends Pharmacol. Sci. 36:3 (2015), 181–186.
10. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E.R., Mizuno, Y., Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93:7 (1996), 2696–2701.
11. Hauser, D.N., Dukes, A.A., Mortimer, A.D., Hastings, T.G., Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4. Free Radic. Biol. Med. 65 (2013), 419–427.
12. Deas, E., Cremades, N., Angelova, P.R., Ludtmann, M.H.R., Yao, Z., Chen, S., et al. Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease. Antioxid. Redox Signal. 24:7 (2016), 376–391.
13. Abeti, R., Uzun, E., Renganathan, I., Honda, T., Pook, M.A., Giunti, P., Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia. Pharmacol. Res. 99 (2015), 344–350.
14. Cong, W.-n., Cai, H., Wang, R., Daimon, C.M., Maudsley, S., Raber, K., et al. Altered hypothalamic protein expression in a rat model of Huntington's disease. PLoS One, 7(10), 2012, e47240.
15. Paul, B.D., Sbodio, J.I., Xu, R., Vandiver, M.S., Cha, J.Y., Snowman, A.M., et al. Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington's disease. Nature 509:7498 (2014), 96–100.
16. Seiler, A., Schneider, M., Forster, H., Roth, S., Wirth, E.K., Culmsee, C., et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 8:3 (2008), 237–248.
17. Tan, S., Schubert, D., Maher, P., Oxytosis: a novel form of programmed cell death. Curr. Top. Med Chem. 1:6 (2001), 497–506.
18. Dolma, S., Lessnick, S.L., Hahn, W.C., Stockwell, B.R., Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3:3 (2003), 285–296.
19. Yang, W.S., SriRamaratnam, R., Welsch, M.E., Shimada, K., Skouta, R., Viswanathan, V.S., et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156:1–2 (2014), 317–331.
20. van Leyen, K., Kim, H.Y., Lee, S.-R., Jin, G., Arai, K., Lo, E.H., Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37:12 (2006), 3014–3018.
21. Yang, W.S., Stockwell, B.R., Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15:3 (2008), 234–245.
22. Landshamer, S., Hoehn, M., Barth, N., Duvezin-Caubet, S., Schwake, G., Tobaben, S., et al. Bid-induced release of AIF from mitochondria causes immediate neuronal cell death. Cell Death Differ. 15:10 (2008), 1553–1563.
23. Grohm, J., Plesnila, N., Culmsee, C., Bid mediates fission, membrane permeabilization and peri-nuclear accumulation of mitochondria as a prerequisite for oxidative neuronal cell death. Brain Behav. Immun. 24:5 (2010), 831–838.
24. Tobaben, S., Grohm, J., Seiler, A., Conrad, M., Plesnila, N., Culmsee, C., Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons. Cell Death Differ. 18:2 (2011), 282–292.
25. Neitemeier, S., Jelinek, A., Laino, V., Hoffmann, L., Eisenbach, I., Eying, R., et al. BID links ferroptosis to mitochondrial cell death pathways. Redox Biol. 12 (2017), 558–570.
26. Culmsee, C., Zhu, C., Landshamer, S., Becattini, B., Wagner, E., Pellecchia, M., et al. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J. Neurosci. 25:44 (2005), 10262–10272.
27. Yang, W.S., Kim, K.J., Gaschler, M.M., Patel, M., Shchepinov, M.S., Stockwell, B.R., Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. USA, 2016.
28. Diemert, S., Dolga, A.M., Tobaben, S., Grohm, J., Pfeifer, S., Oexler, E., et al. Impedance measurement for real time detection of neuronal cell death. J. Neurosci. Methods 203:1 (2012), 69–77.
29. Becattini, B., Sareth, S., Zhai, D., Crowell, K.J., Leone, M., Reed, J.C., et al. Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules. Chem. Biol. 11:8 (2004), 1107–1117.
30. Kelso, G.F., Porteous, C.M., Coulter, C.V., Hughes, G., Porteous, W.K., Ledgerwood, E.C., et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 276:7 (2001), 4588–4596.
31. Becattini, B., Culmsee, C., Leone, M., Zhai, D., Zhang, X., Crowell, K.J., et al. Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid. Proc. Natl. Acad. Sci. USA 103:33 (2006), 12602–12606.
32. Kelso, G.F., Porteous, C.M., Hughes, G., Ledgerwood, E.C., Gane, A.M., Smith, R.A.J., et al. Prevention of mitochondrial oxidative damage using targeted antioxidants. Ann. N. Y Acad. Sci. 959 (2002), 263–274.
33. Pokrzywinski, K.L., Biel, T.G., Kryndushkin, D., Rao, V.A., Therapeutic targeting of the mitochondria initiates excessive superoxide production and mitochondrial depolarization causing decreased mtDNA integrity. PLoS One, 11(12), 2016, e0168283.
34. Oxler, E.-M., Dolga, A., Culmsee, C., AIF depletion provides neuroprotection through a preconditioning effect. Apoptosis 17:10 (2012), 1027–1038.